Clinical Read2026-06-01

Lorundrostat - (Launch-HTN)

Name: Lorundrostat - (Launch-HTN)
Start: 2026-06-01

Mineralys Therapeutics Inc.MLYS

Indication: Uncontrolled hypertension (uHTN) or resistant hypertension (rHTN).
Stage: phase3
Event: Phase 3